Neuroprotection by caspase inhibitors

Bibliography

• ALNEMRI ES, LIVINGSTON DJ, NICHOLSON DW et al: Human ICE/CED-3 protease nomenclature. Cell (1996) 87:171.
   PubMed Web of Science ®Google Scholar
• •Introduction of a new nomenclature.
   Google Scholar
• WILSON KP, BLACK J-AF, THOMSON JA et al.: Structure and mechanism of interleukin-10 converting enzyme. Nature (1994) 370:270–275.
   PubMed Web of Science ®Google Scholar
• SLEE EA, HARTE MT, KLUCK RM et al.: Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell. Biol. (1999) 144:281–292.
   PubMed Web of Science ®Google Scholar
• YUAN J, SHAHAM S, LEDOUX S, ELLIS HM, HORVITZ HR: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell (1993) 75:641–652.
   Google Scholar
• THORNBERRY NA, LAZEBNIK Y: Caspases: enemies within. Science (1998) 281:1312–1316.
   PubMed Web of Science ®Google Scholar
• •Interesting overview of caspase regulation.
   Google Scholar
• REED JC: Bc1-2 family proteins. Oncogene (1998) 17:3225–3236.
   PubMed Web of Science ®Google Scholar
• •Summary of recent findings on Bc1–2.
   Google Scholar
• BREDESEN D: Neural apoptosis. Ann. Neurol. (1995) 38:839–851.
   PubMed Web of Science ®Google Scholar
• •Progress report on the modulators of neural apoptosis.
   Google Scholar
• KUIDA K, HAYDAR TF, KUAN C-Y et al.: Reduced apoptosis and cytochrome c-mediated caspase activa-tion in mice lacking caspase-9. Cell (1998) 94:325–337.
   PubMed Web of Science ®Google Scholar
• KUIDA K, ZHENG TS, NA S et al.: Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature (1996) 384:368–372.
   PubMed Web of Science ®Google Scholar
• •Interesting phenotype of caspase-3 knockout mice.
   Google Scholar
• NICHOLSON DW, THORNBERRY NA: Caspases: killer proteases. TIBS (1997) 260:299–306.
   Google Scholar
• SALVESEN GS, DIXIT VM: Caspases: intracellular signaling by proteolysis. Cell (1997) 91:443–446.
   PubMed Web of Science ®Google Scholar
• •Excellent minireview on caspase activity.
   Google Scholar
• GARCIA-CALVO M, PETERSON EP, LETTING B et al: Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. (1998) 273:32608–32613.
   PubMed Web of Science ®Google Scholar
• •Interesting article on the selectivity of caspase inhibitors.
   Google Scholar
• SCHOTTE P, DECLERCQ W, VAN HUFFEL S, VANDENA- BEELE P, BEYAERT R: Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett. (1999) 442:117–121.
   PubMed Web of Science ®Google Scholar
• THORNBERRY NA, BULL HG, CALAYCAY JR et al.: A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature (1992) 356:768–774.
   PubMed Web of Science ®Google Scholar
• VILLA P, KAUFMANN SH, EARNSHAW WC: Caspases and caspase inhibitors. TIBS (1997) 22:388–393.
   PubMed Web of Science ®Google Scholar
• ••Excellent overview on caspase inhibitors.
   Google Scholar
• THORNBERRY NA: Caspases: key mediators of apoptosis. Chem. Biol. (1998) 5:R97–R103.
   PubMed Web of Science ®Google Scholar
• ZHOU Q, SNIPAS S, ORTH K et al: Target protease specifity of the viral serpin CrmA. Analysis of five caspases. j Biol. Chem. (1997) 272:7797–7800.
   Web of Science ®Google Scholar
• BUMP NJ, HACKETT M, HUGUNIN M et al: Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science (1995) 269: 1885-1888.
   Google Scholar
• DEVERAUX QL, ROY N, STENNICKE HR et al.: IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J (1998) 17:2215–2223.
   PubMed Web of Science ®Google Scholar
• DEVERAUX QL, TAKAHASHI R, SALVESEN GS, REED JC: X-linked IAP is a direct inhibitor of cell-death proteases. Nature (1997) 388:300–304.
   PubMed Web of Science ®Google Scholar
• ROY N, DEVERAUX QL, TAKAHASHI R, SALVESEN GS, REED JC: The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. (1997) 16:6914–6925.
   PubMed Web of Science ®Google Scholar
• CROOK NE, CLEM RJ, MILLER LK: An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J. Virol. (1993) 67:2168–2174.
   PubMed Web of Science ®Google Scholar
• •First report on IAP.
   Google Scholar
• ROY N, MAHADEVAN MS, MCLEAN M et al: The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell (1995) 80:167–178.
   PubMed Web of Science ®Google Scholar
• ••First human TAP identified.
   Google Scholar
• DEVERAUX QL, REED JC: IAP family proteins - suppres- sors of apoptosis. Genes Dev. (1999) 13:239–252.
   PubMed Web of Science ®Google Scholar
• •Comprehensive overview on the IAP family.
   Google Scholar
• HAUSER HP, BARDROFF M, PYROWOLAKIS G, JENTSCH S: A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors. J. Cell Biol. (1998) 141:1415–1422.
   PubMed Web of Science ®Google Scholar
• HINDS MG, NORTON RS, VAUX DL, DAY CL: Solution structure of a baculoviral inhibitor of apoptosis (LAP) repeat. Nature Struct. Biol (1999) 6:648–651.
   PubMedGoogle Scholar
• RANO TA, TIMKEY T, PETERSON EP et al.: A combinato-rial approach for determining protease specificities: application to interleukin-lbeta converting enzyme (ICE). Chem. Biol. (1997) 4:149–155.
   PubMed Web of Science ®Google Scholar
• SLEE EA, ZHU H, CHOW SC et al.: Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. (1996) 315\(Pt1):21–24.
   Google Scholar
• FRIEDLANDER RM, BROWN RH, GAGLIARDINI V, WANGJ, YUAN J: Inhibition of ICE slows ALS in mice. Nature (1997) 388:31.
   PubMed Web of Science ®Google Scholar
• •In vivo significance of caspases in ALS.
   Google Scholar
• HARA H, FINK K, ENDRES M et al.: Attenuation oftransient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein. J. Cereb. Blood Flow Metab. (1997) 17:370–375.
   PubMed Web of Science ®Google Scholar
• SCHIELKE GP, YANG GY, SHIVERS BD, BETZ AL: Reducedischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J. Cereb. Blood Flow Metab. (1998) 18:180–185.
   PubMed Web of Science ®Google Scholar
• CHOI DW: Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. (1996) 6:667–672.
   PubMed Web of Science ®Google Scholar
• •Good overview on the concept of ischaemic apoptosis.
   Google Scholar
• LI Y, SHAROV VG, JIANG N et al.: Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat. Am. J. Pathol. (1995) 146:1045–1051.
   PubMed Web of Science ®Google Scholar
• MACMANUS JP, BUCHAN AM, HILL i.e., RASQUINHA I, PRESTON E: Global ischemia can cause DNA fragmenta-tion indicative of apoptosis in rat brain. Neurosci. Lett. (1993) 164:89–92.
   Google Scholar
• CHEN J, NAGAYAMA T, JIN K et al: Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. (1998) 18:4914–4928.
   PubMed Web of Science ®Google Scholar
• CHENG Y, DESHMUKH M, D'COSTA A et al.: Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-is c hem ic brain injury. J. Clin. Invest. (1998) 101:1992–1999.
   Google Scholar
• ENDRES M, NAMURA S, SHIMIZU-SASAMATA M et al.:Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cereb. Blood Flow Metab. (1998) 18:238–247.
   PubMed Web of Science ®Google Scholar
• •Interesting study on delayed administration of caspase inhibitors.
   Google Scholar
• FINK K, ZHU J, NAMURA S et al.: Prolonged therapeuticwindow for ischemic brain damage caused by delayed caspase activation. J. Cereb. Blood Flow Metab. (1998) 18:1071–1076.
   PubMed Web of Science ®Google Scholar
• HARA H, FRIEDLANDER RM, GAGLIARDINI V et al.:Inhibition of interleukin lb converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA (1997) 94:2007-2012. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1999) 8(10)
   Google Scholar
• HIMI T, ISHIZAKI Y, MUROTA S: A caspase inhibitorblocks ischaemia-induced delayed neuronal death in the gerbil. Eur. j Neurosci. (1998) 10:777–781.
   PubMed Web of Science ®Google Scholar
• LODDICK SA, MACKENZIE A, ROTHWELL NJ: An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat. Neuroreport (1996) 7:1465–1468.
   PubMed Web of Science ®Google Scholar
• •First application of a caspase inhibitor in cerebral ischaemia.
   Google Scholar
• FRIEDLANDER RM, GAGLIARDINI V, Hara H et al: Expres- sion of a dominant negative mutant of interleukin-113 converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J. Exp. Med. (1997) 185:933–940.
   PubMed Web of Science ®Google Scholar
• •Interesting genetic study on the role of caspase-1 in cerebral ischaemia.
   Google Scholar
• MA J, ENDRES M, MOSKOWITZ MA: Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischaemia in mice. Br. J. Pharmacol. (1998) 124:756–762.
   PubMed Web of Science ®Google Scholar
• SCHULZ JB, WELLER M, MATTHEWS RT et al: Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia. Cell Death Differ. (1998) 5:847–857.
   PubMed Web of Science ®Google Scholar
• LISTON P, ROY N, TAMAI K et al.: Suppression of apoptosis in mammalian cells by NALP and a related family of IAP genes. Nature (1996) 379:349–353.
   PubMed Web of Science ®Google Scholar
• XU D, BUREAU Y, MCINTYRE DC et al.: Attenuation ofischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. j Neurosci. (1999) 19:5026–5033.
   PubMed Web of Science ®Google Scholar
• XU DG, CROCKER SJ, DOUCET J-P et al.: Elevation ofneuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nature Med. (1997) 3:997–1004.
   PubMed Web of Science ®Google Scholar
• •Interesting appraoch to decrease ischaemia damage.
   Google Scholar
• SIMONS M, BEINROTH S, GLEICHMANN M et al.: Adenovirus-mediated gene transfer of inhibitors of apoptosis protein delays apoptosis in cerebellar granule neurons. J. Neurochem. (1999) 72:292–301.
   PubMed Web of Science ®Google Scholar
• ZYSK G, BRUCK W, GERBER J et al: Anti-inflammatorytreatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J. Neuropathol. Exp. Neurol (1996) 55:722–728.
   PubMed Web of Science ®Google Scholar
• •First description on apoptosis in meningitis.
   Google Scholar
• BRAUN JS, NOVAK R, HERZOG K-H et al.: Neuroprotec- tion by a caspase inhibitor in acute bacterial meningitis. Nature Med. (1999) 5:298–302.
   PubMed Web of Science ®Google Scholar
• •First application of a caspase inhibitor in meningitis.
   Google Scholar
• BITZER M, PRINZ F, BAUER M et al.: Sendai virusinfection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32). J. Vim]: (1999) 73:702–708.
   Google Scholar
• GRIFFIN DE, LEVINE B, UBOL S, HARDWICK JM: Theeffects of alphavirus infection on neurons. Ann. Neurol (1994) 35:S23–S27.
   PubMed Web of Science ®Google Scholar
• JACKSON AC, ROSSITER JP: Apoptosis plays animportant role in experimental rabies virus infection. Virol. (1997) 71:5603–5607.
   Web of Science ®Google Scholar
• MCQUAID S, MCMAHON J, HERRON B, COSBY SL: Apoptosis in measles virus-infected human central nervous system tissues. Neuropathol. Appl. Neurobiol (1997) 23:218–224.
   PubMed Web of Science ®Google Scholar
• OBERHAUS SM, SMITH RL, CLAYTON GH, DERMODY TS, TYLER KL: Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. j Vim]. (1997) 71:2100–2106.
   Web of Science ®Google Scholar
• SHI B, DEGIROLAMI U, HE J et al: Apoptosis induced by 11IV-1 infection of the central nervous system. J. Clin. Invest. (1996) 98:1979–1990.
   PubMed Web of Science ®Google Scholar
• ALLSOPP TE, SCALLAN MF, WILLIAMS A, FAZAKERLEY JK: Virus infection induces neuronal apoptosis: a comparison with trophic factor withdrawal. Cell Death Differ. (1998) 5:50–59.
   PubMed Web of Science ®Google Scholar
• NAVA VE, ROSEN A, VELIUONA MA et al.: Sindbis virus induces apoptosis through a caspase-dependent, CrmA-sensitive pathway. J. Vim]. (1998) 72:452–459.
   Web of Science ®Google Scholar
• LEWIS J, WESSELINGH SL, GRIFFIN DE, HARDWICK JM: Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J. Vim]. (1996) 70:1828–1835.
   Web of Science ®Google Scholar
• LEWIS J, OYLER GA, UENO K et al.: Inhibition of virus-induced neuronal apoptosis by Bax. Nature Merl. (1999) 5:832–835.
   PubMed Web of Science ®Google Scholar
• •Provoking new role of Bax.
   Google Scholar
• BITTIGAU P, SIFRINGER M, POHL D et al.: Apoptoticneurodegeneration following trauma is markedly enhanced in the immature brain. Ann. Neurol. (1999) 45:724–735.
   PubMed Web of Science ®Google Scholar
• CLARK RSB, KOCHANEK PM, CHEN M et al.: Increases inBc1-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J. (1999) 13:813–821.
   PubMed Web of Science ®Google Scholar
• PIKE BR, ZHAO X, NEWCOMB JK et al.: Regional calpainand caspase-3 proteolysis of alpha-spectrin after traumatic brain injury. Neuroreport (1998) 9:2437–2442.
   PubMed Web of Science ®Google Scholar
• YAKOVLEV AG, KNOBLACH SM, FAN L et al.: Activationof CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J. Neurosci. (1997) 17:7415–7424.
   PubMed Web of Science ®Google Scholar
• •Important study on caspase activation and inhibition in this model.
   Google Scholar
• BERKELAAR M, CLARKE DB, WANG YC, BRAY GM, AGUAYO AJ: Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J. Neurosci. (1994) 14:4368–4374.
   PubMed Web of Science ®Google Scholar
• GARCIA-VALENZUELA E, GORCZYCA W, DARZYNKIEWICZ Z, SHARMA SC: Apoptosis in adult retinal ganglion cells after axotomy. J. Neurobiol (1994) 25:431–438.
   PubMedGoogle Scholar
• QUIGLEY HA, NICKELLS RW, KERRIGAN LA et al. Retinal ganglion cell death in experimental glaucoma and © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1999) 8(10) after axotomy occurs by apoptosis. Invest. Ophthalmol. Vis. Sci. (1995) 36:774–786.
   PubMed Web of Science ®Google Scholar
• CHAUDHARY P, AHMED F, QUEBADA P, SHARMA SC: Caspase inhibitors block the retinal ganglion cell death following optic nerve transection. Mol Brain Res. (1999) 67:36–45.
   PubMedGoogle Scholar
• HOLTZMAN DM, DESHMUKH M: Caspases: a treatmenttarget for neurodegenerative disease? Nature Med. (1997) 3:954–955.
   Google Scholar
• MIZUNO Y, MOCHIZUKI H, SUGITA Y, GOTO K: Apoptosis in neurodegenerative disorders. Intern. Merl. (1998) 37:192–193.
   PubMed Web of Science ®Google Scholar
• BARINAGA M: Is apoptosis key in Alzheimer's disease? Science (1998) 281:1303–1304.
   PubMed Web of Science ®Google Scholar
• STEFANIS L, BURKE RE, GREENE LA: Apoptosis in neurodegenerative disorders. Curr. Opin. Neurol. (1997) 10:299–305.
   PubMed Web of Science ®Google Scholar
• SELKOE DJ: Translating cell biology into therapeuticadvances in Alzheimer's disease. Nature (1999) 399:A23–31.
   PubMed Web of Science ®Google Scholar
• •Recent review on advances in this field.
   Google Scholar
• ANDERSON AJ, SU JH, COTMAN CW: DNA damage andapoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci. (1996) 16:1710–1719.
   PubMed Web of Science ®Google Scholar
• LI WP, CHAN WY, LAI HW, YEW DT: Terminal dUTP nickend labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients. J. Mol. Neurosci. (1997) 8:75–82.
   PubMed Web of Science ®Google Scholar
• SMALE G, NICHOLS NR, BRADY DR, FINCH CE, HORTON WEJ: Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol. (1995) 133:225–230.
   PubMed Web of Science ®Google Scholar
• LEBLANC A: Increased production of 4 kDa amyloid beta peptide in serum deprived human primary neuron cultures: possible involvement of apoptosis. J. Neurosci. (1995) 15:7837–7846.
   PubMed Web of Science ®Google Scholar
• GERVAIS FG, XU D, ROBERTSON GS et al.: Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-B precursor protein and amyloidogenic AB peptide formation. Cell (1999) 97:395–406.
   PubMed Web of Science ®Google Scholar
• ••Interesting new model.
   Google Scholar
• WEIDEMANN A, PALIGA K, DeRRWANG U et al.: Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. J. Biol. Chem. (1999) 274:5823–5829.
   PubMed Web of Science ®Google Scholar
• MOECHARS D, LORENT K, VAN LEUVEN F: Premature death in transgenic mice that overexpress a mutant amyloid precursor protein is preceded by severe neurodegeneration and apoptosis. Neuroscience (1999) 91:818–830.
   Web of Science ®Google Scholar
• LOO DT, COPANI A, PIKE CJ et al.: Apoptosis is inducedby beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA (1993) 90:7951–7955.
   PubMed Web of Science ®Google Scholar
• WEIHL CC, GHADGE GD, KENNEDY SG et al.: Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. j Neurosci. (1999) 19:5360–5369.
   PubMed Web of Science ®Google Scholar
• JORDAN J, GALINDO MF, MILLER RJ: Role of calpain- and interleukin-1B converting enzyme-like proteases in the B-amyloid-induced death of rat hippocampal neurons in culture. J. Neurochem. (1997) 68:1612–1621.
   PubMed Web of Science ®Google Scholar
• HARPER PS: Huntington's disease. W.B. Saunders, London (1991).
   Google Scholar
• Butterworth NJ, Williams L, Bullock JY et al.: Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum. Neuroscience (1998) 87:49–53.
   PubMed Web of Science ®Google Scholar
• PORTERA-CAILLIAU C, HEDREEN JC, PRICE DL, KOLIATSOS VE: Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. Neurosci. (1995) 15:3775–3787.
   PubMed Web of Science ®Google Scholar
• SANCHEZ I, XU CJ, JUO P et al.: Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neurone (1999) 22:623–633
   PubMed Web of Science ®Google Scholar
• SAUDOU F, FINKBEINER S, DEVYS D, GREENBERG ME:Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell (1998) 95:55–66.
   PubMed Web of Science ®Google Scholar
• •Important article on mutant Huntingtin.
   Google Scholar
• ONA VO, LI M, VONSATTEL JPG et al.: Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature (1999) 399:263–267.
   PubMed Web of Science ®Google Scholar
• ••Evidence of caspase-1 in Huntington's pathogenesis.
   Google Scholar
• MANGIARINI L, SATHASIVAM K, SELLER M etal: Exon 1 of the HDgene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell (1996) 87:493–506.
   PubMed Web of Science ®Google Scholar
• ROSEN DR, SIDDIQUE T, PATTERSON D et al.: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature (1993) 362:59–62.
   PubMed Web of Science ®Google Scholar
• GURNEY ME, PU H, CHIU AY et al.: Motor neurondegeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science (1994) 264:1772–1775.
   PubMed Web of Science ®Google Scholar
• •Animal model of ALS.
   Google Scholar
• MARTIN LJ: Neuronal death in amyotrophic lateralsclerosis is apoptosis: possible contribution of a programmemed cell death mechanism. J. Neuropathol Exp. Neurol. (1999) 58:459–471.
   PubMed Web of Science ®Google Scholar
• PASINELLI P, BORCHELT DR, HOUSEWEART MK, CLEVELAND DW, BROWN JR RH: Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc. Natl. Acad. Sci. USA (1998) 95:15763–15768.
   PubMed Web of Science ®Google Scholar
• GHADGE GD, LEE JP, BINDOKAS VP et al.: Mutantsuperoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J. Neurosci. (1997) 17:8756-8766. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1999) 8(10)
   Google Scholar
• POLLARD H, CHARRIAUT-MARLANGUE C, CANTAGREL S et al.: Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience (1994) 63:7–18.
   PubMed Web of Science ®Google Scholar
• GILLARDON F, BOTTIGER B, SCHMITZ B, ZIMMERMANN M, HOSSMANN KA: Activation of CPP-32 protease in hippocampal neurons following ischemia and epilepsy. Brain Res. Mol. Brain Res. (1997) 50:16–22.
   PubMedGoogle Scholar
• NATH R, PROBERT JR A, MCGINNIS KM, WANG KKW: Evidence for activation of caspase-3-like protease in excitotoxin- and hypoxia/hypoglycemia-injured neurons. J. Neurochem. (1998) 71:186–195.
   PubMed Web of Science ®Google Scholar
• HAASS C: Dead end for neurodegeneration? Nature (1999) 399:204–207.
   PubMed Web of Science ®Google Scholar
• DESHMUKH M, VASILAKOS J, DECKWERTH TL et al: Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases. J. Cell Biol. (1996) 135:1341–1354.
   PubMed Web of Science ®Google Scholar
• GREEN DR: Apoptotic pathways: the roads to ruin. Cell (1998) 94:695–698.
   PubMed Web of Science ®Google Scholar
• ••Compact minireview on apoptotic pathways.
   Google Scholar